B/F/TAF
GS-US-380-5310
Phase 1 small_molecule completed
Quick answer
B/F/TAF for HIV-1-infection is a Phase 1 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences Ireland UC
- Indication
- HIV-1-infection
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed